NCT04171934 (Nelli) is a clinical trial in Epilepsy; Seizure, sponsored by Tampere University.

Who is sponsoring NCT04171934?

NCT04171934 is sponsored by Tampere University.

What condition does NCT04171934 study?

NCT04171934 studies Epilepsy; Seizure.

Is NCT04171934 still recruiting?

NCT04171934 is currently completed. Last updated 13 October 2022.

Last reviewed 2022-10-13 · How we verify

NCT04171934: Nelli

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Validation of a Video-based Epilepsy Examination Service

Completed Last updated 13 October 2022

What this trial tests

trial in Epilepsy; Seizure in 182 participants. Completed in 15 December 2021.

Timeline

17 June 2019

Primary endpoint
2 July 2021

15 December 2021

Quick facts

Lead sponsor	Tampere University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	182
Start date	17 June 2019
Primary completion	2 July 2021
Estimated completion	15 December 2021
Sites	1 location across Denmark

Conditions studied

Epilepsy; Seizure — all drugs for Epilepsy; Seizure →

Sponsor

Tampere University

Who can join

Eligibility, any sex, with Epilepsy; Seizure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main purpose of this study is to validate the ability of the Nelli system (video-based epilepsy examination system) to detect epileptic motor seizure behaviors in patients at rest.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Epilepsy; Seizure

Currently open trials in the same condition.

NCT06278428 — Genotype, Phenotype, and Disease Progression of Developmental Epileptic Encephalopathy With Onset Before 2 Years of Age · recruiting
NCT04569708 — Sleep Spindles and Memory in Rolandic Epilepsy · NA · recruiting
NCT06617845 — Optimizing Brain Stimulation Parameters · NA · recruiting

Other Tampere University trials

Trials by the same sponsor.

NCT05786001 — Multimodal Noninvasive Assessment of Peripheral Circulation in Chronic Limb-threatening Ischemia · recruiting
NCT07131371 — Stratification, Management, and Guidance of Hypertrophic Cardiomyopathy Patients Using Hybrid Digital Twin Solutions · active not recruiting
NCT06322511 — Dialogical Family Guidance PostDoc Study · NA · recruiting
NCT05766202 — The MOTIVE (Multiparas Overcoming Childbirth Fear Through Intervention and Empowerement) Feasibility Trial · NA · completed
NCT05626543 — The Effect of Mindfulness-based Cognitive Behavior Therapy on Occupational Stress Management · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04171934 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tampere University
Last refreshed: 13 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04171934.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing